Search results
Roche Holding AG (OTCMKTS:RHHBY) Receives $40.00 Consensus Target Price from Brokerages
ETF DAILY NEWS· 2 days agoRoche Holding AG (OTCMKTS:RHHBY – Get Free Report) has earned an average rating of “Hold” from the seven brokerages that are presently covering the stock, MarketBeat reports ...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 5 days agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 6 days agoStocks recently featured in the blog include: Novo Nordisk NVO, Eli Lilly’s LLY, Viking Therapeutics...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 2 days agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 2 days agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks· 2 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
WJET - WFXP Erie· 2 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual...
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan...
Benzinga· 5 days agoThe Structure Therapeutics GPCR stock has been identified as a potential winner in the obesity drug...
Mairs & Power Growth Fund's 1st-Quarter Commentary: A Review
Guru Focus· 6 days agoThe market's performance continues to hinge on the “Magnificent 7” Technology stocks, which have...
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma...
Benzinga· 3 days agoThe Biden administration has urged the U.S. Supreme Court to reconsider a ruling involving 21...